Expert insights. Personalized for you.
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset MORE
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. MORE
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
266 
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned. MORE
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. A study in JAMA published this week analyzed research reports that have measured waste in the U.S. MORE
National health spending in the U.S. is expected to grow by 5.7% MORE
My cousin Arlene got married in Detroit at the classic Book Cadillac Hotel on July 23, 1967, a Sunday afternoon wedding. When Daddy drove us back out to our suburban home about 30 minutes from the fancy hotel, the car radio was tuned to WWJ Newsradio 950, all news all the time. MORE
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health. MORE
Among all Americans, the most popular approach for improving the health care in the U.S. isn’t repealing or replacing the Affordable Care Act or moving to a Medicare-for-All government-provided plan. MORE
On the demand side of U.S. health care economics, patients are now payors as health consumers with more financial skin in paying medical bills. MORE
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People MORE
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. MORE
239 
In America, earning lower or middle incomes is a risk factor for having trouble accessing health care and/or paying for it. MORE
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin MORE
The technology has a built-in sensor that can send usage data to a corresponding smartphone app. MORE
206 
The coronavirus pandemic has further opened the kimono of the U.S. healthcare system to Americans: four months into the COVID-19 outbreak, most consumers (62%) of people in the U.S. are more concerned about other people not having access to high quality health care versus themselves. MORE
Patients in the U.S. are self-rationing care in the era of COVID-19 by cutting spending on health care visits and prescription drugs. MORE
It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart. MORE
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses. MORE
Bio/life sciences Financial toxicity Health Consumers Health costs Health policy Health politics media and health Medicaid Medicare Medicines Pharmaceutical Pharmacy Prescription drugs Retail health Specialty drugs Transparency Women and health MORE
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. MORE
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. MORE
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs MORE
Industry leaders across medtech and pharmaceutical sectors applaud proposal for its forward thinking MORE
135 
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients MORE
262 
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers. MORE
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards. MORE
COVID-19 is re-shaping health care in America across many dimensions. In Shifts in Healthcare Demand, Delivery and Care During the COVID-19 Era , IQVIA presents a multi-faceted profile of the early impacts of the pandemic on U.S. health care. MORE
Coronavirus COVID-19 Death Demographics and health Financial health Financial wellness Health citizenship Health Consumers Health costs Health disparities Health Economics Health equity Medicines Pharmaceutical Prescription drugs Race and health Social determinants of health MORE
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. MORE
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores. MORE
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
210 A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. MORE
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs). MORE
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019. MORE
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. People in the U.S. MORE
From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […]. MORE
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S. MORE
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year MORE
223 
Pharmaceuticals Related Topics 
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Electronic Health Reporter
AUGUST 3, 2020
From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Electronic Health Reporter
AUGUST 28, 2018
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.
Mobi Health News
JULY 16, 2020
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year
Mobi Health News
JULY 15, 2019
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.
|
Digital Health
FEBRUARY 3, 2020
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin
Health Populi
JULY 30, 2020
Coronavirus COVID-19 Death Demographics and health Financial health Financial wellness Health citizenship Health Consumers Health costs Health disparities Health Economics Health equity Medicines Pharmaceutical Prescription drugs Race and health Social determinants of health
Electronic Health Reporter
OCTOBER 25, 2018
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.
FierceHealthIT
JUNE 22, 2018
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset
Health Populi
OCTOBER 8, 2019
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. A study in JAMA published this week analyzed research reports that have measured waste in the U.S.
|
|
Mobi Health News
AUGUST 3, 2020
Industry leaders across medtech and pharmaceutical sectors applaud proposal for its forward thinking
Health Populi
JULY 15, 2019
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores.
Health Populi
JULY 16, 2019
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute.
Health Populi
JUNE 18, 2020
Bio/life sciences Financial toxicity Health Consumers Health costs Health policy Health politics media and health Medicaid Medicare Medicines Pharmaceutical Pharmacy Prescription drugs Retail health Specialty drugs Transparency Women and health
Health Populi
APRIL 17, 2019
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0.
Health Populi
MAY 14, 2020
COVID-19 is re-shaping health care in America across many dimensions. In Shifts in Healthcare Demand, Delivery and Care During the COVID-19 Era , IQVIA presents a multi-faceted profile of the early impacts of the pandemic on U.S. health care.
Health Populi
JUNE 9, 2020
The coronavirus pandemic has further opened the kimono of the U.S. healthcare system to Americans: four months into the COVID-19 outbreak, most consumers (62%) of people in the U.S. are more concerned about other people not having access to high quality health care versus themselves.
Health Populi
OCTOBER 15, 2019
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S.
Health Populi
JULY 11, 2019
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses.
Health Populi
MAY 20, 2020
Patients in the U.S. are self-rationing care in the era of COVID-19 by cutting spending on health care visits and prescription drugs.
Health Populi
MARCH 29, 2019
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S.
Health Populi
OCTOBER 28, 2019
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. People in the U.S.
Health Populi
DECEMBER 2, 2019
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned.
Health Populi
JANUARY 29, 2019
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs
Mobi Health News
JUNE 23, 2019
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients
Health Populi
APRIL 24, 2019
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population.
Health Populi
FEBRUARY 6, 2020
Among all Americans, the most popular approach for improving the health care in the U.S. isn’t repealing or replacing the Affordable Care Act or moving to a Medicare-for-All government-provided plan.
Health Populi
JANUARY 30, 2020
In America, earning lower or middle incomes is a risk factor for having trouble accessing health care and/or paying for it.
Health Populi
FEBRUARY 21, 2019
National health spending in the U.S. is expected to grow by 5.7%
Health Populi
AUGUST 7, 2019
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019.
Health Populi
AUGUST 7, 2018
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.
Health Populi
MARCH 6, 2019
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them.
Health Populi
NOVEMBER 5, 2019
On the demand side of U.S. health care economics, patients are now payors as health consumers with more financial skin in paying medical bills.
Health Populi
NOVEMBER 19, 2019
My cousin Arlene got married in Detroit at the classic Book Cadillac Hotel on July 23, 1967, a Sunday afternoon wedding. When Daddy drove us back out to our suburban home about 30 minutes from the fancy hotel, the car radio was tuned to WWJ Newsradio 950, all news all the time.
Health Populi
MARCH 15, 2018
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).
Health Populi
AUGUST 6, 2018
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.
Health Populi
JUNE 18, 2019
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards.
Health Populi
APRIL 26, 2019
It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart.
Let's personalize your content